Results 41 to 50 of about 14,968 (77)

Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology [PDF]

open access: yes, 2011
Familial adenomatous polyposis patients are at risk of duodenal cancer. Surveillance is indicated and the extent of duodenal polyposis is quantified by the Spigelman staging system.
Elisabeth M. H. Mathus-Vliegen   +3 more
core   +2 more sources

Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. [PDF]

open access: yes, 2002
OBJECTIVES: To report on the phenotypic spectrum and clinical management of Chinese patients suffering from the rare autosomal dominant colorectal cancer syndrome of familial adenomatous polyposis.
Chu, KM, Ho, JW, Tse, CW, Yuen, ST
core  

Testing the Children: Do Non-Genetic Health-Care Providers Differ in Their Decision to Advise Genetic Presymptomatic Testing on Minors? A Cross-Sectional Study in Five Countries in the European Union [PDF]

open access: yes, 2009
BACKGROUND: Within Europe many guidelines exist regarding the genetic testing of minors. Predictive and presymptomatic genetic testing of minors is recommended for disorders for which medical intervention/preventive measures exist, and for which early ...
Anne Marie C. Plass   +15 more
core   +1 more source

Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: A multicentre, randomized controlled trial [PDF]

open access: yes, 2013
. Background: Due to prophylactic colectomy, mortality in patients with familial adenomatous polyposis (FAP) has changed, with duodenal cancer currently being the main cause of death. Although celecoxib reduces duodenal polyp density in patients with FAP,
Dees, J. (Jan)   +11 more
core   +1 more source

Familial adenomatous patients with desmoid tumours show increased expression of miR-34a in serum and high levels in tumours

open access: yes, 2016
Familial adenomatous polyposis (FAP) is rare affecting 1 in 10,000 people and a subset (10%) are at risk of myofibroblastic desmoid tumours (DTs) after colectomy to prevent cancer. DTs are a major cause of morbidity and mortality.
Clark, SK   +9 more
core   +1 more source

Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis [PDF]

open access: yes, 2012
Familial adenomatous polyposis (FAP) is an autosomal dominant cancer predisposition syndrome that accounts for approximately 0.5–1% of all colorectal cancer cases.
Abraham   +36 more
core   +1 more source

Poliposis familiar hereditaria y síndrome de Gardner: aportación de la exploración odontoestomatológica a su diagnóstico y descripción de un caso [PDF]

open access: yes, 2005
La poliposis adenomatosa familiar (PAF) y su variante fenotípica, el síndrome de Gardner, constituyen una infrecuente patología hereditaria autosómica dominante.
Blanco, Ignacio   +3 more
core   +1 more source

Colorectal Cancer: Epidemiological Trends, Screening, and Inheritability [PDF]

open access: yes, 2018
Colorectal cancer is one of the most common cancer worldwide. The incidence and mortality trend in different areas of the world varies. Colorectal cancer incidence and mortality are increasing in some countries.
Maulahela, H. (Hasan)   +2 more
core  

Central blood volume in cirrhosis [PDF]

open access: yes, 1993
Bendtsen, Flemming   +2 more
core   +1 more source

Re:Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk [PDF]

open access: yes, 2005
A. Tenesa   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy